ProKidney Corp. (PROK)
ProKidney Market Cap: 315.65M for Jan. 22, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Lineage Cell Therapeutics, Inc. | 390.41M |
| Nautilus Biotechnology, Inc. | 274.08M |
| Neumora Therapeutics, Inc. | 337.52M |
| CEL-SCI Corp. | 18.15M |
| AIM ImmunoTech, Inc. | 3.471M |
Market Cap Related Metrics
| PS Ratio | 391.71 |
| Price | 2.23 |
| Earnings Yield | -24.42% |